# MONALEESA-7 (NCT02278120)

> Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02278120
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Novartis Pharmaceuticals
- Conditions: Advanced Metastatic Breast Cancer
- Interventions: Ribociclib; Tamoxifen; Letrozole; Anastrozole; Goserelin; Placebo
- Enrollment: 672
- Primary outcome: Progression Free Survival (PFS) by Investigator Assessment

## Commentary we found

- YouTube: 10
- Podcasts: 8
- X threads: 5

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=monaleesa-7-nct02278120

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02278120", "email": "<work email>"}; the inbox owner confirms by the emailed link.